These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 22257644)

  • 1. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
    Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
    J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
    Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
    Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
    Chu SY; Yeter K; Kotha R; Pong E; Miranda Y; Phung S; Chen H; Lee SH; Leung I; Bonzon C; Desjarlais JR; Stohl W; Szymkowski DE
    Arthritis Rheumatol; 2014 May; 66(5):1153-64. PubMed ID: 24782179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
    Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
    Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
    Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
    Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved FcγRIIb targeting functionally translates into enhanced inhibition of basophil activation.
    Buschor P; Eggel A; Zellweger F; Stadler BM; Vogel M
    Int Arch Allergy Immunol; 2014; 163(3):206-14. PubMed ID: 24557487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.
    Sherr E; Macy E; Kimata H; Gilly M; Saxon A
    J Immunol; 1989 Jan; 142(2):481-9. PubMed ID: 2521348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity against a therapeutic xenoprotein/Fc construct delivered by gene transfer is reduced through binding to the inhibitory receptor FcγRIIb.
    Liang Y; Qiu H; Glinka Y; Lazarus AH; Ni H; Prud'homme GJ; Wang Q
    J Gene Med; 2011 Sep; 13(9):470-7. PubMed ID: 21786368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
    Corren J; Diaz-Sanchez D; Saxon A; Deniz Y; Reimann J; Sinclair D; Davancaze T; Adelman D
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):243-8. PubMed ID: 15478383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
    Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
    Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The murine lymphocyte receptor for IgE. I. Isolation and characterization of the murine B cell Fc epsilon receptor and comparison with Fc epsilon receptors from rat and human.
    Conrad DH; Peterson LH
    J Immunol; 1984 Feb; 132(2):796-803. PubMed ID: 6228601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy.
    Weigmann B; Schughart N; Wiebe C; Sudowe S; Lehr HA; Jonuleit H; Vogel L; Becker C; Neurath MF; Grabbe S; Saloga J; Bellinghausen I
    J Allergy Clin Immunol; 2012 Apr; 129(4):1126-35. PubMed ID: 22236728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of murine lymphocyte IgE receptors by flow microfluorometry.
    Katona IM; Urban JF; Titus JA; Stephany DA; Segal DM; Finkelman FD
    J Immunol; 1984 Sep; 133(3):1521-8. PubMed ID: 6235289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor Fc gamma RIIB expression on B cells.
    Victor JR; Muniz BP; Fusaro AE; de Brito CA; Taniguchi EF; Duarte AJ; Sato MN
    BMC Immunol; 2010 Mar; 11():11. PubMed ID: 20222978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
    Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
    Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
    Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.